 James Lambert
Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 5 | 2016 | 58 | 1.470 |
Why?
| | Growth Differentiation Factor 15 | 6 | 2019 | 41 | 1.310 |
Why?
| | Receptors, Steroid | 3 | 2015 | 45 | 0.930 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2018 | 216 | 0.890 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2016 | 168 | 0.870 |
Why?
| | Antineoplastic Agents | 9 | 2024 | 2202 | 0.830 |
Why?
| | Neoplasm Proteins | 2 | 2016 | 444 | 0.760 |
Why?
| | Vitamin D | 4 | 2024 | 400 | 0.730 |
Why?
| | Prostatic Neoplasms | 7 | 2019 | 979 | 0.690 |
Why?
| | Focal Adhesions | 2 | 2016 | 47 | 0.570 |
Why?
| | Cell Line, Tumor | 15 | 2024 | 3560 | 0.490 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2024 | 1462 | 0.480 |
Why?
| | Actin Cytoskeleton | 1 | 2016 | 103 | 0.460 |
Why?
| | Receptors, Glucocorticoid | 4 | 2015 | 138 | 0.440 |
Why?
| | Response Elements | 3 | 2015 | 89 | 0.440 |
Why?
| | Cell Adhesion | 1 | 2016 | 455 | 0.430 |
Why?
| | Prostatitis | 1 | 2014 | 17 | 0.430 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2008 | 533 | 0.420 |
Why?
| | Cell Movement | 3 | 2024 | 965 | 0.400 |
Why?
| | Prostate | 1 | 2014 | 158 | 0.390 |
Why?
| | Connective Tissue Growth Factor | 1 | 2013 | 27 | 0.390 |
Why?
| | Transcription, Genetic | 5 | 2013 | 1496 | 0.390 |
Why?
| | Receptors, Calcitriol | 2 | 2010 | 55 | 0.390 |
Why?
| | Cell Proliferation | 4 | 2024 | 2506 | 0.380 |
Why?
| | Promoter Regions, Genetic | 7 | 2015 | 1260 | 0.370 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 286 | 0.340 |
Why?
| | Gene Expression Regulation | 5 | 2015 | 2609 | 0.340 |
Why?
| | Alkylating Agents | 1 | 2010 | 24 | 0.330 |
Why?
| | NF-kappa B | 1 | 2014 | 662 | 0.330 |
Why?
| | Prostatic Hyperplasia | 1 | 2008 | 40 | 0.270 |
Why?
| | Cell Hypoxia | 1 | 2008 | 247 | 0.270 |
Why?
| | Apoptosis | 6 | 2024 | 2430 | 0.260 |
Why?
| | Calcifediol | 1 | 2007 | 31 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 381 | 0.240 |
Why?
| | Kidney Neoplasms | 1 | 2010 | 413 | 0.240 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2006 | 142 | 0.230 |
Why?
| | DNA Damage | 1 | 2008 | 430 | 0.230 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 931 | 0.230 |
Why?
| | Protein Binding | 4 | 2015 | 2283 | 0.230 |
Why?
| | Mammary Tumor Virus, Mouse | 2 | 2015 | 45 | 0.220 |
Why?
| | Melanoma | 2 | 2021 | 761 | 0.210 |
Why?
| | Signal Transduction | 7 | 2024 | 5239 | 0.200 |
Why?
| | DNA | 3 | 2015 | 1467 | 0.190 |
Why?
| | Anti-Bacterial Agents | 2 | 2011 | 1922 | 0.190 |
Why?
| | Receptors, Progesterone | 2 | 2013 | 357 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2024 | 437 | 0.170 |
Why?
| | Neoplasms | 3 | 2024 | 2887 | 0.160 |
Why?
| | Trans-Activators | 1 | 2003 | 405 | 0.160 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2020 | 39 | 0.160 |
Why?
| | Organoselenium Compounds | 1 | 2019 | 11 | 0.150 |
Why?
| | Aniline Compounds | 1 | 2020 | 119 | 0.150 |
Why?
| | Transcriptional Activation | 5 | 2012 | 383 | 0.150 |
Why?
| | Nuclear Proteins | 2 | 2008 | 750 | 0.150 |
Why?
| | Histones | 2 | 2010 | 673 | 0.140 |
Why?
| | Protein Multimerization | 3 | 2015 | 214 | 0.140 |
Why?
| | Humans | 27 | 2024 | 145307 | 0.140 |
Why?
| | Transfection | 3 | 2016 | 940 | 0.140 |
Why?
| | Thermodynamics | 3 | 2015 | 426 | 0.130 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 592 | 0.130 |
Why?
| | Cell Division | 2 | 2012 | 766 | 0.130 |
Why?
| | Phosphorylation | 2 | 2013 | 1735 | 0.130 |
Why?
| | Prodigiosin | 2 | 2007 | 2 | 0.130 |
Why?
| | Tryptophan | 1 | 2018 | 182 | 0.130 |
Why?
| | Neoplasm Invasiveness | 2 | 2016 | 510 | 0.120 |
Why?
| | Matrix Metalloproteinase 10 | 1 | 2016 | 3 | 0.120 |
Why?
| | rac GTP-Binding Proteins | 1 | 2016 | 35 | 0.120 |
Why?
| | Laminin | 1 | 2016 | 72 | 0.120 |
Why?
| | Sulfonamides | 1 | 2020 | 581 | 0.120 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2016 | 76 | 0.120 |
Why?
| | Cell Cycle | 2 | 2010 | 600 | 0.120 |
Why?
| | src-Family Kinases | 1 | 2016 | 93 | 0.120 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 173 | 0.110 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2016 | 191 | 0.110 |
Why?
| | Oncogenes | 1 | 2016 | 119 | 0.110 |
Why?
| | Ultracentrifugation | 1 | 2015 | 51 | 0.110 |
Why?
| | Mice, Nude | 2 | 2020 | 688 | 0.110 |
Why?
| | RNA Interference | 1 | 2016 | 476 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2021 | 847 | 0.100 |
Why?
| | Atrophy | 1 | 2014 | 201 | 0.100 |
Why?
| | Luteolin | 1 | 2013 | 4 | 0.100 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 697 | 0.100 |
Why?
| | Quercetin | 1 | 2013 | 18 | 0.100 |
Why?
| | Receptors, Estrogen | 2 | 2015 | 458 | 0.100 |
Why?
| | Integrin alphaVbeta3 | 1 | 2013 | 20 | 0.100 |
Why?
| | Homeodomain Proteins | 2 | 2010 | 530 | 0.100 |
Why?
| | Two-Hybrid System Techniques | 1 | 2013 | 59 | 0.100 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2013 | 32 | 0.100 |
Why?
| | Mutation, Missense | 1 | 2015 | 340 | 0.100 |
Why?
| | Animals | 11 | 2024 | 38180 | 0.100 |
Why?
| | Endocrine Disruptors | 1 | 2013 | 45 | 0.100 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2013 | 108 | 0.090 |
Why?
| | Sodium Chloride | 1 | 2012 | 142 | 0.090 |
Why?
| | Mice | 7 | 2024 | 18397 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 701 | 0.090 |
Why?
| | Antigens, CD | 1 | 2014 | 555 | 0.090 |
Why?
| | Steroid Hydroxylases | 1 | 2011 | 20 | 0.080 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2011 | 16 | 0.080 |
Why?
| | Salmonella typhi | 1 | 2011 | 12 | 0.080 |
Why?
| | Cytokines | 2 | 2011 | 2066 | 0.080 |
Why?
| | Evolution, Molecular | 1 | 2015 | 517 | 0.080 |
Why?
| | Cyclin A | 1 | 2010 | 18 | 0.080 |
Why?
| | Alkylation | 1 | 2010 | 27 | 0.080 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2010 | 5 | 0.080 |
Why?
| | Blotting, Western | 2 | 2010 | 1187 | 0.080 |
Why?
| | Immunoenzyme Techniques | 1 | 2010 | 200 | 0.080 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 477 | 0.080 |
Why?
| | Caspases | 1 | 2010 | 232 | 0.080 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 371 | 0.070 |
Why?
| | Receptors, Androgen | 1 | 2010 | 153 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2013 | 576 | 0.070 |
Why?
| | Tumor Cells, Cultured | 1 | 2010 | 920 | 0.070 |
Why?
| | Male | 10 | 2019 | 72629 | 0.070 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2008 | 5 | 0.070 |
Why?
| | CREB-Binding Protein | 2 | 2010 | 34 | 0.070 |
Why?
| | Cell Count | 1 | 2008 | 322 | 0.070 |
Why?
| | RNA Stability | 1 | 2008 | 119 | 0.070 |
Why?
| | Huntington Disease | 1 | 2008 | 61 | 0.070 |
Why?
| | Acetylation | 2 | 2010 | 256 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 112 | 0.060 |
Why?
| | Fibroblast Growth Factors | 1 | 2008 | 188 | 0.060 |
Why?
| | Rats, Nude | 1 | 2006 | 25 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2007 | 81 | 0.060 |
Why?
| | Corpus Striatum | 1 | 2008 | 179 | 0.060 |
Why?
| | RNA, Neoplasm | 1 | 2006 | 86 | 0.060 |
Why?
| | Doxorubicin | 1 | 2008 | 398 | 0.060 |
Why?
| | Escherichia coli | 1 | 2011 | 855 | 0.060 |
Why?
| | Biological Transport | 1 | 2007 | 418 | 0.060 |
Why?
| | Transplantation, Heterologous | 1 | 2006 | 194 | 0.060 |
Why?
| | Calcium | 1 | 2012 | 1185 | 0.060 |
Why?
| | Tumor Suppressor Proteins | 1 | 2008 | 324 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 512 | 0.060 |
Why?
| | Time Factors | 1 | 2016 | 7186 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2008 | 437 | 0.050 |
Why?
| | Cell Survival | 2 | 2024 | 1099 | 0.050 |
Why?
| | Female | 7 | 2024 | 78605 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2007 | 479 | 0.050 |
Why?
| | DNA Footprinting | 2 | 2015 | 33 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 758 | 0.050 |
Why?
| | Binding Sites | 3 | 2012 | 1333 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 70 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 439 | 0.050 |
Why?
| | Imidazoles | 1 | 2024 | 254 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2024 | 381 | 0.040 |
Why?
| | Uveal Neoplasms | 1 | 2021 | 16 | 0.040 |
Why?
| | Precancerous Conditions | 1 | 2003 | 166 | 0.040 |
Why?
| | Autophagy | 1 | 2024 | 286 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4580 | 0.040 |
Why?
| | Breast Neoplasms | 3 | 2013 | 2464 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2008 | 1503 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 241 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 561 | 0.040 |
Why?
| | Tryptophan Oxygenase | 1 | 2018 | 33 | 0.030 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.030 |
Why?
| | Rats | 1 | 2006 | 5616 | 0.030 |
Why?
| | Gene Expression Profiling | 2 | 2019 | 1787 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 220 | 0.030 |
Why?
| | Disease Progression | 1 | 2024 | 2855 | 0.030 |
Why?
| | Androgens | 2 | 2010 | 186 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2015 | 68 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1048 | 0.020 |
Why?
| | Luciferases | 1 | 2012 | 152 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 675 | 0.020 |
Why?
| | Proteomics | 1 | 2019 | 1195 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1371 | 0.020 |
Why?
| | Kinetics | 1 | 2015 | 1630 | 0.020 |
Why?
| | Hydrodynamics | 1 | 2011 | 47 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2010 | 162 | 0.020 |
Why?
| | RNA, Messenger | 2 | 2008 | 2833 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2010 | 192 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2191 | 0.020 |
Why?
| | Huntingtin Protein | 1 | 2008 | 13 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2008 | 140 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1619 | 0.020 |
Why?
| | Dioxoles | 1 | 2007 | 9 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2931 | 0.020 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2007 | 57 | 0.020 |
Why?
| | Genes, Neoplasm | 1 | 2007 | 25 | 0.020 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 31 | 0.020 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2007 | 72 | 0.020 |
Why?
| | Benzamides | 1 | 2007 | 227 | 0.010 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 187 | 0.010 |
Why?
| | Down-Regulation | 1 | 2008 | 627 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 983 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4156 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 593 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2010 | 1126 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1718 | 0.010 |
Why?
| | Chromosome Aberrations | 1 | 2003 | 163 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2008 | 2192 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2008 | 2053 | 0.010 |
Why?
| | Transcription Factors | 1 | 2008 | 1746 | 0.010 |
Why?
| | Phenotype | 1 | 2008 | 3173 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 36021 | 0.000 |
Why?
|
|
Lambert's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|